Clinical Trial: Whole Gut Motility Abnormalities Following GLP-1 Receptor Agonist (GLP-1RA) Initiation

U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07784127) titled 'Whole Gut Motility Abnormalities Following GLP-1 Receptor Agonist (GLP-1RA) Initiation' on Aug. 17.

Brief Summary: Participants will undergo evaluation with the Atmo capsule at two time points: at baseline before starting the GLP-1RA or dual agonist therapy and after the subject has been taking their GLP-1RA or dual agonist therapy for 3 months. The total expected time for patient participation is up to 4 months from the time they start their GLP-1RA or dual agonist therapy.

Study Start Date: Dec., 2026

Study Type: INTERVENTIONAL

Condition: Diabetes

Intervention: PROCEDURE: Gut motility quantification using a capsule after ini...